| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| 16pter |
SYNGR3 |
Synaptogyrin 3 |
603927 |
|
|
A |
|
| 16pter-p13.3 |
HBA1 |
Hemoglobin alpha-1 |
141800 |
Thalassemias, alpha-, 604131 (3); Methemoglobinemias, alpha- (3);Erythremias, alpha- (3); Heinz body anemias, alpha-, 140700 (3) |
1, 2, or 3 loci;5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3' |
HS |
11(Hba) |
| 16pter-p13.3 |
HBA2 |
Hemoglobin alpha-2 |
141850 |
Thalassemia, alpha-, 604131 (3); Hemoglobin H disease (3); Heinz bodyanemia, 140700 (3); Erythrocytosis (3); Hypochromic microcytic anemia (3) |
|
HS |
11(Hba) |
| 16pter-p13.3 |
HBQ1 |
Hemoglobin theta-1 |
142240 |
|
|
RE |
|
| 16pter-p13.3 |
HBZ |
Hemoglobin, zeta |
142310 |
|
|
RE |
|
| 16pter-p13.3 |
HBHR, ATR1 |
Alpha-thalassemia/mental retardation syndrome, type 1 |
141750 |
Alpha-thalassemia/mental retardation syndrome, type 1 (1) |
contiguous gene syndrome involving deletion of HBA1 and HBA2 |
Fd, RE, D |
|
| 16pter-p13.3 |
MPG, MDG |
N-methylpurine DNA glycosylase |
156565 |
|
75kb upstream of HBZ |
REa, REn |
11(Mpg) |
| 16pter-p13 |
CHDS1 |
Coronary heart disease, susceptibility to, 1 |
607339 |
{Coronary heart disease, susceptibility to} (2) |
|
Fd |
|
| 16pter-p11 |
ZNF75A |
Zinc finger protein-75A |
601473 |
|
|
REa |
|
| 16p13.3 |
ABAT, GABAT |
4-aminobutyrate aminotransferase |
137150 |
GABA-transaminase deficiency (3) |
|
R |
|
| 16p13.3 |
ABCA3, ABC3, SMDP3 |
ATP-binding cassette-3 |
601615 |
Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3) |
|
REc |
|
| 16p13.3 |
ADCY9 |
Adenylate cyclase-9 |
603302 |
|
|
A |
16(Adcy9) |
| 16p13.3 |
ALG1, HMAT1, HMT1 |
Alg1, yeast, homolog of (beta-1,4 mannosyltransferase) |
605907 |
Congenital disorder of glycosylation, type Ik, 608540 (3) |
|
REc |
|
| 16p13.3 |
AXIN1, AXIN |
Axis inhibitor 1 |
603816 |
Hepatocellular carcinoma, somatic, 114550 (3); Caudal duplicationanomaly, 607864 (3) |
|
REc |
|
| 16p13.3 |
ATP6V0C, ATP6L, ATP6C |
ATPase, H+ transporting, lysosomal, 16kD, V0 subunit c |
108745 |
|
|
REc |
|
| 16p13.3 |
BAIAP3, BAP3 |
BAI1-associated protein 3 |
604009 |
|
|
A, R |
|
| 16p13.3 |
C16orf5 |
Chromosome 16 open reading frame 5 |
610503 |
|
|
A, Psh |
|
| 16p13.3 |
C16orf30, CLP24 |
Claudin-like protein 24 |
611002 |
|
|
REc |
|
| 16p13.3 |
CACNA1H, EIG6, ECA6 |
Calcium channel, voltage-dependent, T type, alpha-1H subunit |
607904 |
{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3);{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3) |
|
R, A |
17(Cacna1h) |
| 16p13.3 |
CASKIN1, KIAA1306 |
CASK-interacting protein 1 |
612184 |
|
|
R, REc |
|
| 16p13.3 |
CCNF, FBX1 |
Cyclin F |
600227 |
|
|
REn |
17(Ccnf) |